This is a recurrent theme that is similarly observed in AML with RUNX1::RUNX1T1 fusion, as the resultant chimeric fusion proteins have also been shown to mediate the recruitment of chromatin-modifying enzymes to target genes [19]. Here, RUNX1 is linked to acute myeloid leukemia.